We are on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments. We are working to transform the treatment paradigm for mental health …

atai Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. [1][2][3][4][5] It was founded in …

AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

2 days ago · Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in …

1 day ago · Needham on Monday initiated coverage on Atai Life Sciences NV (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on developing treatments for mental health.

atai Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018...

1 day ago · Atai Beckley's top institutional investors include OP Asset Management Ltd (0.12%). Insiders that own company stock include Apeiron Investment Group Ltd, Life Sciences NV Atai, Florian …

3 days ago · AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.

2 days ago · Stock analysis for AtaiBeckley Inc (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Aug 15, 2025 · Planned strategic combination between atai Life Sciences and Beckley Psytech Limited to create a global leader in short in-clinic psychedelic-based mental health therapies is expected to …